Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs

PUBT · 2d ago
Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs
  • Tempus AI won FDA 510(k) clearance for Tempus ECG-PH, an AI tool that flags signs of pulmonary hypertension from standard 12-lead ECGs.
  • The software targets symptomatic patients aged 40 or older with no known pulmonary hypertension, supporting earlier risk identification in clinical settings.
  • It is the company’s third FDA-cleared cardiovascular device, expanding its regulated AI product portfolio.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260824141676) on August 24, 2026, and is solely responsible for the information contained therein.